Search Results - jeffery+miller

2 Results

Sort By:

2022-085: MULTI-EPITOPE MRNA SARS-COV-2 VACCINE FOR BOOSTING IMMUNITY THROUGH THE ACTIVATION OF CD4 AND CD8 T CELLS AS WELL AS B LYMPHOCYTES

SUMMARY: UCLA Researchers in the Division of Nanomedicine and Microbiology, Immunology and Molecular Genetics have developed a new SARS-CoV-2 vaccine that provides long lasting and robust immunity. BACKGROUND: An effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) constitutes a major global health priority. While multiple...

Published: 2/14/2025 | Inventor(s): Andre Nel, Tian Xia, Jeffery Miller

Keywords(s):

Category(s): Therapeutics, Therapeutics > Infectious Diseases, Therapeutics > Vaccines, Therapeutics > Infectious Diseases > COVID

Discovery of Novel Anti-Infectives for Gram Negative Pathogens (UCLA Case No. 2019-255)

UCLA researchers in the California NanoSystems Institute have discovered novel and potent therapeutic agents against Burkholderia bacteria, E. Coli and pseudomonas bacterial infections through cell-based phenotypic screening that are more effective than existing treatments. BACKGROUND: Burkholderia pseudomallei (Bp) and Burkholderia mallei (Bm) cause...

Published: 6/26/2025 | Inventor(s): Jeffery Miller, Robert Damoiseaux

Keywords(s): Infectious Diseases, Therapeutics & Vaccines

Category(s): Therapeutics > Infectious Diseases